LLY
ELI LILLY & Co
NYSE · Healthcare · Drug Manufacturers - General · US
$1,414.27
+0.35%Margins
Gross margin
83.6%
EBITDA margin
51.8%
EBIT margin
46.1%
Net margin
31.9%
FCF margin
22.7%
68.5%
Return on equity
18.6%
Return on assets
44.4%
Return on invested capital
0.60x
Asset turnover
$30.6B
Cash from operations
$5.19
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026